Dr. Claudia Fischbach's lab at Cornell University is focused on understanding how the mechanical properties of adipose tissue influence breast cancer, particularly in the context of obesity. The research investigates how changes in adipose tissue and fat cells affect tumor invasion and metastasis. By combining computational models, cell culture techniques, and analysis of human specimens, the lab aims to uncover new insights that could potentially improve patient outcomes in breast cancer.

Dr. Nelly Andarawis-Puri's lab at Cornell University focuses on understanding and treating common tendon injuries known as tendinopathies. The research aims to develop better therapeutic strategies to promote healing and repair through exercise and other interventions in tendon injuries. By investigating the biological mechanisms behind tendon repair and degeneration, the lab seeks to improve diagnostic and treatment options for patients suffering from these conditions.

Dr. Minseok Lee's lab at Cornell University is focused on innovative approaches to treat type 1 diabetes by developing advanced devices for cell delivery. The lab's research aims to create a subcutaneous device that can improve the transplantation of insulin-producing cells while avoiding the need for long-term immunosuppression. This work could lead to safer and more effective therapies for individuals suffering from diabetes.

Dr. Shaoyi Jiang's lab at Cornell University focuses on understanding how lipid nanoparticles (LNPs) interact with the immune system. By studying the immunogenicity of these nanoparticles, the lab aims to identify which components of LNPs cause adverse immune responses, particularly in the context of vaccine development. Their research seeks to improve the safety and effectiveness of LNPs used in vaccines and therapeutics.

Dr. Ilana Lauren Brito's lab at Cornell University focuses on understanding how proteins from human hosts interact with those from the microbiome, which are crucial for health and disease. The research is aimed at discovering new protein-protein interactions (PPIs) between hosts and microbiome organisms, using advanced computational models and experimental techniques. This work can lead to insights into microbiome-related disorders and potentially identify new therapeutic targets.

Dr. Michael O. Thompson's lab focuses on developing advanced detector technologies for brain Positron Emission Tomography (PET). Their work aims to enhance imaging performance, which is crucial for diagnosing and studying brain diseases like Alzheimer's and dementia. The lab's innovations will lead to better diagnostic tools that can improve patient care, especially as the population ages.

Dr. Chris B. Schaffer's lab at Cornell University focuses on understanding how blood flow in the brain affects cognitive functions related to Alzheimer's Disease (AD) and other related dementias. The research investigates how improving blood circulation can enhance memory and correct neural activity imbalances in mouse models. This work aims to uncover mechanisms that could potentially lead to new therapies for cognitive symptoms in AD.

Chris Xu's lab at Cornell University focuses on developing innovative imaging techniques to capture high-resolution images of living tissues, particularly in neuroscience. The lab aims to overcome current limitations in optical imaging technologies, enabling researchers to visualize brain structures and functions deeply and rapidly. This research not only enhances our understanding of neural systems but also contributes to advances in various biomedical fields.